Age and Gender Differences in the Pattern of Antiplatelet Agents Prescribing

References (20)

1. 1 Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [DOI]
2. 2 Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack [DOI]
3. 3 Ambulatory care visits of physician offices, hospital outpatient departments, and emergency departments: United States, 1995.
4. 4 Gender differences in the utilization of health-care services among the older adult population of Spain [DOI]
5. 5 Sex Differences in Platelet Reactivity and Response to Low-Dose Aspirin Therapy [DOI]
6. 6 Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis [DOI]
7. 7 Applying Quality Measures and Guidelines in the Management of Acute Coronary Syndrome and Venous Thromboembolism Introduction [DOI]
8. 8 Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998–2010 [DOI]
9. 9 Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A ‘state-of-the-art’ paper [DOI]
10. 10 Evidence for Age and Sex Differences in the Secondary Prevention of Stroke in Scottish Primary Care [DOI]
11. 11 Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, Spain [DOI]
12. 12 Reported current use of prescription drugs and some of its determinants among 35 to 65-year-old women in mid-Sweden [DOI]
13. 13 Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry [DOI]
14. 14 Gender Differences in Drug Use and Expenditures in a Privately Insured Population of Older Adults [DOI]
15. 15 Sex Differences in Treatment Patterns of Six Chronic Diseases: An Analysis from the German Statutory Health Insurance [DOI]
16. 16 Gender and Age Differences in Medications Dispensed from a National Chain Drugstore [DOI]
17. 17 Making use of official statistics in research on gender and health status: recent British data [DOI]
18. 18 Sex Differences in Antiplatelet Response in Ischemic Stroke [DOI]
19. 19 Use of chronic medications among a large, commercially‐insured US population [DOI]
20. 20 Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA? [DOI]

Cited by 3

Related research

• Causes, Investigations and Treatment of Acute Coronary Syndrome — shares topic coverage
• The Use of Anticoagulants and Antiplatelet Agents among Outpatients in Alkharj — shares topic coverage
• Combination of Oral Anticoagulant with Antiplatelet and All-cause Mortality in Elderly Patients with Atrial Fibrillation and Ischemic Heart Disease — shares topic coverage
• Antiplatelet Agents Utilization Pattern and Assessment of Patient Specific Drug use Problems among Cardiac Patient — shares topic coverage
• Utilization Patterns of Anticoagulant and Antiplatelet Drugs in Cardiovascular Patients at a Tertiary Care Hospital — shares topic coverage